Substituted tetracycline compounds
US7820641B2 · kind B2 · utility
22Cited by
78References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2003 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | Jan 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/46
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.